{"id":"https://openalex.org/W4212913883","doi":"https://doi.org/10.1200/jco.2022.40.6_suppl.tps597","title":"Randomized comparator-controlled study evaluating efficacy and safety of pembrolizumab plus Bacillus Calmette-Gu\u00e9rin (BCG) in patients with high-risk nonmuscle-invasive bladder cancer (HR NMIBC): KEYNOTE-676 cohort B.","display_name":"Randomized comparator-controlled study evaluating efficacy and safety of pembrolizumab plus Bacillus Calmette-Gu\u00e9rin (BCG) in patients with high-risk nonmuscle-invasive bladder cancer (HR NMIBC): KEYNOTE-676 cohort B.","publication_year":2022,"publication_date":"2022-02-16","ids":{"openalex":"https://openalex.org/W4212913883","doi":"https://doi.org/10.1200/jco.2022.40.6_suppl.tps597"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2022.40.6_suppl.tps597","doi":"https://doi.org/10.1200/jco.2022.40.6_suppl.tps597","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2022.40.6_suppl.tps597","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034005227","display_name":"Ashish M. Kamat","orcid":"https://orcid.org/0000-0003-3546-9928","observed_orcids":["https://orcid.org/0000-0003-3546-9928"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ashish M. Kamat","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079401169","display_name":"Shahrokh Fran\u00e7ois Shariat","orcid":"https://orcid.org/0000-0002-6627-6179","observed_orcids":["https://orcid.org/0000-0002-6627-6179"]},"institutions":[{"id":"https://openalex.org/I76134821","display_name":"Medical University of Vienna","ror":"https://ror.org/05n3x4p02","country_code":"AT","type":"education","lineage":["https://openalex.org/I76134821"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"Shahrokh Shariat","raw_affiliation_strings":["Medical University of Vienna, Vienna, Austria;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical University of Vienna, Vienna, Austria;","institution_ids":["https://openalex.org/I76134821"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055374861","display_name":"Gary D. Steinberg","orcid":"https://orcid.org/0000-0003-4469-0624","observed_orcids":["https://orcid.org/0000-0003-4469-0624"]},"institutions":[{"id":"https://openalex.org/I4210086933","display_name":"NYU Langone Health","ror":"https://ror.org/005dvqh91","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210086933"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gary D. Steinberg","raw_affiliation_strings":["NYU Langone Health, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NYU Langone Health, New York, NY;","institution_ids":["https://openalex.org/I4210086933"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015190969","display_name":"Shaheen Riadh Alanee","orcid":"https://orcid.org/0000-0002-1585-4557","observed_orcids":["https://orcid.org/0000-0002-1585-4557"]},"institutions":[{"id":"https://openalex.org/I2800326109","display_name":"Detroit Medical Center","ror":"https://ror.org/05gehxw18","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800326109"]},{"id":"https://openalex.org/I87216513","display_name":"Michigan State University","ror":"https://ror.org/05hs6h993","country_code":"US","type":"education","lineage":["https://openalex.org/I87216513"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shaheen Riadh Alanee","raw_affiliation_strings":["Michigan State University and the Detroit Medical Center, Detroit, MI;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Michigan State University and the Detroit Medical Center, Detroit, MI;","institution_ids":["https://openalex.org/I2800326109","https://openalex.org/I87216513"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071455815","display_name":"Hiroyuki Nishiyama","orcid":"https://orcid.org/0000-0001-7423-596X","observed_orcids":["https://orcid.org/0000-0001-7423-596X"]},"institutions":[{"id":"https://openalex.org/I146399215","display_name":"University of Tsukuba","ror":"https://ror.org/02956yf07","country_code":"JP","type":"education","lineage":["https://openalex.org/I146399215"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hiroyuki Nishiyama","raw_affiliation_strings":["University of Tsukuba, Tsukuba, Japan;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Tsukuba, Tsukuba, Japan;","institution_ids":["https://openalex.org/I146399215"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110742321","display_name":"Kijoeng Nam","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kijoeng Nam","raw_affiliation_strings":["Merck & Co., Inc., Kenilworth, NJ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Kenilworth, NJ;","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042803921","display_name":"Ekta Kapadia","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ekta Kapadia","raw_affiliation_strings":["Merck & Co., Inc., Kenilworth, NJ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Kenilworth, NJ;","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088518998","display_name":"Neal D. Shore","orcid":"https://orcid.org/0000-0001-5767-0548","observed_orcids":["https://orcid.org/0000-0001-5767-0548"]},"institutions":[{"id":"https://openalex.org/I4210165013","display_name":"Carolina Urologic Research Center","ror":"https://ror.org/05vk9vy20","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210165013"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Neal D. Shore","raw_affiliation_strings":["Carolina Urologic Research Center, Myrtle Beach, SC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Carolina Urologic Research Center, Myrtle Beach, SC;","institution_ids":["https://openalex.org/I4210165013"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5001308517","display_name":"Noah M. Hahn","orcid":"https://orcid.org/0000-0002-1016-9024","observed_orcids":["https://orcid.org/0000-0002-1016-9024"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Noah M. Hahn","raw_affiliation_strings":["Johns Hopkins University School of Medicine, Baltimore, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johns Hopkins University School of Medicine, Baltimore, MD;","institution_ids":["https://openalex.org/I145311948"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":9,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"40","issue":"6_suppl","first_page":"TPS597","last_page":"TPS597"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10279","display_name":"Urinary Bladder and Prostate Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.9929999709129333},{"id":"https://openalex.org/keywords/bcg-vaccine","display_name":"BCG vaccine","score":0.9760000109672546},{"id":"https://openalex.org/keywords/carcinoma-in-situ","display_name":"carcinoma in situ","score":0.8510000109672546},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitor-combination-therapy","display_name":"immune checkpoint inhibitor combination","score":0.7129999995231628},{"id":"https://openalex.org/keywords/bcg-maintenance-therapy","display_name":"BCG maintenance therapy","score":0.6119999885559082},{"id":"https://openalex.org/keywords/pd-l1-expression","display_name":"PD-L1 expression","score":0.9020000100135803},{"id":"https://openalex.org/keywords/treatment-naive-patients","display_name":"treatment-naive patients","score":0.640999972820282},{"id":"https://openalex.org/keywords/recurrence-free-survival","display_name":"recurrence-free survival","score":0.5360000133514404},{"id":"https://openalex.org/keywords/disease-free-survival","display_name":"disease-free survival","score":0.5130000114440918},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.4950000047683716},{"id":"https://openalex.org/keywords/bcg-unresponsive-disease","display_name":"BCG-unresponsive disease","score":0.6209999918937683},{"id":"https://openalex.org/keywords/bladder-cancer-recurrence","display_name":"bladder cancer recurrence","score":0.3109999895095825}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9379044771194458},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.9193756580352783},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.7118356227874756},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5710101127624512},{"id":"https://openalex.org/C2780352672","wikidata":"https://www.wikidata.org/wiki/Q504775","display_name":"Bladder cancer","level":3,"score":0.5380401611328125},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.49900341033935547},{"id":"https://openalex.org/C2778769751","wikidata":"https://www.wikidata.org/wiki/Q246090","display_name":"Cystoscopy","level":3,"score":0.44313934445381165},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3266482651233673},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.3127819001674652},{"id":"https://openalex.org/C77411442","wikidata":"https://www.wikidata.org/wiki/Q181100","display_name":"Urinary system","level":2,"score":0.15541839599609375}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2022.40.6_suppl.tps597","doi":"https://doi.org/10.1200/jco.2022.40.6_suppl.tps597","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2022.40.6_suppl.tps597","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3202080513","https://openalex.org/W4391303624","https://openalex.org/W2502912613","https://openalex.org/W2947275031","https://openalex.org/W3202356372","https://openalex.org/W2922234680","https://openalex.org/W3010696323","https://openalex.org/W4324136951","https://openalex.org/W2588401808","https://openalex.org/W4391303586"],"abstract_inverted_index":{"TPS597":[0],"Background:":[1],"Cohort":[2,81,95,130],"A":[3,82],"of":[4,40,49,69,132,164,253,301,327],"the":[5,65,177,292],"phase":[6,55],"2":[7,125,179],"KEYNOTE-057":[8],"study":[9,58,293,302,348],"showed":[10],"that":[11,48,103],"pembrolizumab":[12,70,107,189,204],"monotherapy":[13,75,217],"provided":[14],"effective":[15],"antitumor":[16],"activity":[17],"and":[18,67,151,171,230,257,294,345,363],"acceptable":[19],"safety":[20,68],"in":[21,29,33,76,110,357],"patients":[22,77,85,113,138],"with":[23,27,35,78,86,139,276],"BCG-unresponsive":[24],"HR":[25,41,79,90,145],"NMIBC":[26,42,91,146,224],"carcinoma":[28],"situ":[30],"(CIS).":[31],"Pembrolizumab":[32],"combination":[34],"BCG":[36,50,72,74,93,109,111,118,122,175,199,210,216],"at":[37,355],"earlier":[38],"stages":[39],"might":[43],"provide":[44],"benefit":[45],"superior":[46],"to":[47,63,187,296,341,353],"monotherapy.":[51],"The":[52,309,347],"open-label,":[53],"comparator-controlled,":[54],"3":[56],"KEYNOTE-676":[57,133],"(NCT03711032)":[59],"will":[60,83,104,134,182,248,280,288],"be":[61,183,249,289],"conducted":[62],"investigate":[64],"efficacy":[66],"+":[71,108,198,209],"versus":[73],"NMIBC.":[80],"enroll":[84,135,354],"persistent":[87],"or":[88,120,215,227,238,351],"recurrent":[89],"after":[92,299],"induction.":[94],"B":[96,131],"is":[97,313,349],"a":[98],"new,":[99],"randomly":[100,184],"assigned":[101,185],"cohort":[102],"help":[105],"evaluate":[106],"treatment\u2013naive":[112],"who":[114,160],"either":[115],"never":[116],"received":[117,121,174],"treatment":[119,123,303],">":[124],"years":[126],"before":[127,169],"enrollment.":[128],"Methods:":[129],"approximately":[136],"975":[137],"blinded":[140],"independent":[141],"central":[142,244],"review":[143],"(BICR)\u2013confirmed":[144],"(T1,":[147],"high-grade":[148],"Ta":[149],"CIS)":[150,229],"Eastern":[152],"Cooperative":[153],"Oncology":[154],"Group":[155],"performance":[156],"status":[157,247],"score":[158,235],"0-2":[159],"underwent":[161],"cystoscopy/transurethral":[162],"resection":[163],"bladder":[165],"tumor":[166],"\u226412":[167],"weeks":[168,196,263,271],"randomization":[170],"had":[172],"not":[173],"within":[176],"past":[178],"years.":[180],"Patients":[181],"1:1:1":[186],"receive":[188],"400":[190,205],"mg":[191,206],"intravenously":[192],"(IV)":[193],"every":[194,261,269,282],"6":[195],"(Q6W)":[197],"reduced":[200],"maintenance":[201,212],"(\u22646":[202],"months),":[203,214],"IV":[207],"Q6W":[208],"full":[211,219],"(\u226418":[213],"(BCG":[218],"maintenance).":[220],"Stratification":[221],"factors":[222],"include":[223,320],"stage":[225],"(CIS":[226,333],"no":[228],"PD-L1":[231],"expression":[232],"(combined":[233],"positive":[234],"[CPS]":[236],"\u226510":[237],"CPS":[239],"<":[240],"10),":[241],"determined":[242],"by":[243,251,324],"laboratory.":[245],"Disease":[246],"assessed":[250],"use":[252],"cystoscopy,":[254],"urine":[255],"cytology,":[256],"biopsy":[258],"(as":[259],"applicable)":[260],"12":[262],"(Q12W)":[264],"through":[265,272],"year":[266,273],"2,":[267],"then":[268],"24":[270],"5;":[274],"imaging":[275],"computed":[277],"tomography":[278],"urography":[279],"occur":[281],"72":[283],"weeks.":[284],"Adverse":[285],"events":[286],"(AEs)":[287],"monitored":[290],"throughout":[291],"up":[295],"30":[297],"days":[298,305],"cessation":[300],"(90":[304],"for":[306],"serious":[307],"AEs).":[308],"primary":[310],"end":[311,318],"point":[312],"event-free":[314],"survival":[315],"(EFS).":[316],"Secondary":[317],"points":[319],"complete":[321],"response":[322,328],"rate":[323,332],"BICR,":[325],"duration":[326],"(DOR),":[329],"12-month":[330],"DOR":[331],"only),":[334],"24-month":[335],"EFS":[336],"rate,":[337],"disease-specific":[338],"survival,":[339,344],"time":[340],"cystectomy,":[342],"overall":[343],"safety.":[346],"enrolling":[350],"planning":[352],"sites":[356],"Asia,":[358],"Australia,":[359],"Europe,":[360],"North":[361],"America,":[362],"South":[364],"America.":[365],"Clinical":[366],"trial":[367],"information:":[368],"NCT03711032.":[369]},"counts_by_year":[{"year":2025,"cited_by_count":3}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2022-02-24T00:00:00"}